Catamenial epilepsy may involve 10 to 70% of women with epilepsy in which, seizures are exacerbat... more Catamenial epilepsy may involve 10 to 70% of women with epilepsy in which, seizures are exacerbated by the menstrual cycle. Artemisinin is a herbal compound with widespread modern and traditional medical indications. Because of GABAergic interaction, this study was designed to study the antiepileptic effects of artemisinin during the estrus cycle. 360 adult female mice in 10 groups: control, solvent (ethanol 10ml/kg) Artemisinin (75&150 mg/kg), Bicuculline (2mg/kg), Bicuculline (2mg/kg) + Atremisinin (75&150 mg/kg), Saclofen (2mg/kg), Saclofen(2mg/kg) + Atremisinin (75&150 mg/kg), each with four subgroups (proestrus, estrus, metestrus and diestrus) were used(n=9). After one week of acclimatization, estrous synchronization and phase determination was achieved. Acute epilepsy was induced by intraperitoneal (i.p) injection of 80 mg/kg of Pentylentetrazole (PTZ), 30 minutes after i.p injection of artemisinin, and ethanol, then Initiation time of myoclonic seizures (ITMS), initiation time of tonic–clonic seizures (ITTS), seizures duration (SD) and mortality rate (MR) were recorded for 30 minutes. Data were displayed as mean ± SD and evaluated using One-way ANOVA followed by Tukey–Kramer multiple comparison post hoc test (P<0.05). Artemisinin significantly decreased epilepsy incidence, duration, and mortality rate, in parallel to increasing ITMS and ITTS dose-dependently, which were more prominent during the luteal phase. Co-administration of Biccucluline significantly inhibited antiepileptic effects of Artemisinin, while saclofen did not has such an inhibitory interaction. It seems that increased neurosteroid metabolites and GABA receptors, neural hyperpolarization following GABAA interaction, anti-inflammatory and anti-oxidative properties which decrease neuroinflammation and neural excitability can participate in the antiepileptic effects of artemisinin.
Catamenial epilepsy may involve 10 to 70% of women with epilepsy in which, seizures are exacerbat... more Catamenial epilepsy may involve 10 to 70% of women with epilepsy in which, seizures are exacerbated by the menstrual cycle. Artemisinin is a herbal compound with widespread modern and traditional medical indications. Because of GABAergic interaction, this study was designed to study the antiepileptic effects of artemisinin during the estrus cycle. 360 adult female mice in 10 groups: control, solvent (ethanol 10ml/kg) Artemisinin (75&150 mg/kg), Bicuculline (2mg/kg), Bicuculline (2mg/kg) + Atremisinin (75&150 mg/kg), Saclofen (2mg/kg), Saclofen(2mg/kg) + Atremisinin (75&150 mg/kg), each with four subgroups (proestrus, estrus, metestrus and diestrus) were used(n=9). After one week of acclimatization, estrous synchronization and phase determination was achieved. Acute epilepsy was induced by intraperitoneal (i.p) injection of 80 mg/kg of Pentylentetrazole (PTZ), 30 minutes after i.p injection of artemisinin, and ethanol, then Initiation time of myoclonic seizures (ITMS), initiation time of tonic–clonic seizures (ITTS), seizures duration (SD) and mortality rate (MR) were recorded for 30 minutes. Data were displayed as mean ± SD and evaluated using One-way ANOVA followed by Tukey–Kramer multiple comparison post hoc test (P<0.05). Artemisinin significantly decreased epilepsy incidence, duration, and mortality rate, in parallel to increasing ITMS and ITTS dose-dependently, which were more prominent during the luteal phase. Co-administration of Biccucluline significantly inhibited antiepileptic effects of Artemisinin, while saclofen did not has such an inhibitory interaction. It seems that increased neurosteroid metabolites and GABA receptors, neural hyperpolarization following GABAA interaction, anti-inflammatory and anti-oxidative properties which decrease neuroinflammation and neural excitability can participate in the antiepileptic effects of artemisinin.
Uploads
Papers by Jahangir Kaboutari
Artemisinin significantly decreased epilepsy incidence, duration, and mortality rate, in parallel to increasing ITMS and ITTS dose-dependently, which were more prominent during the luteal phase. Co-administration of Biccucluline significantly inhibited antiepileptic effects of Artemisinin, while saclofen did not has such an inhibitory interaction. It seems that increased neurosteroid metabolites and GABA receptors, neural hyperpolarization following GABAA interaction, anti-inflammatory and anti-oxidative properties which decrease neuroinflammation and neural excitability can participate in the antiepileptic effects of artemisinin.
Artemisinin significantly decreased epilepsy incidence, duration, and mortality rate, in parallel to increasing ITMS and ITTS dose-dependently, which were more prominent during the luteal phase. Co-administration of Biccucluline significantly inhibited antiepileptic effects of Artemisinin, while saclofen did not has such an inhibitory interaction. It seems that increased neurosteroid metabolites and GABA receptors, neural hyperpolarization following GABAA interaction, anti-inflammatory and anti-oxidative properties which decrease neuroinflammation and neural excitability can participate in the antiepileptic effects of artemisinin.